FLGT
HEALTHCAREFulgent Genetics Inc
AI Insight
What's Moving FLGT Today?
No stock-specific AI insight has been generated for FLGT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$13.46$31.04
$18.18
Fundamentals
Market Cap$513M
P/E Ratio—
EPS$-2.40
Dividend Yield—
Dividend / Share—
ROE-6.9%
Profit Margin-23.0%
Debt / Equity—
Trading
Volume256K
Avg Volume (10D)—
Shares Outstanding28.4M
FLGT News
22 articles- How The Fulgent Genetics (FLGT) Investment Story Is Evolving With Recent DevelopmentsYahoo Finance·Jun 7, 2026
- Fulgent Presents Updated FID-007 Data at ASCO 2026Stock Titan·Jun 1, 2026
- Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual MeetingYahoo Finance·May 21, 2026
- Fulgent Genetics infertility test panels broaden to cover over 140 genes for females and 160 for malesTraders Union·May 13, 2026
- Foundation Medicine to Launch FoundationOne®PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent GeneticsYahoo Finance·May 4, 2026
- Fulgent Genetics Inc (FLGT) Q1 2026 Earnings Call Highlights: Navigating Challenges with ...Yahoo Finance·May 2, 2026
- Fulgent Genetics, Inc. Q1 2026 Earnings Call SummaryMoby·May 1, 2026
- Fulgent Genetics Q1 Earnings Call HighlightsMarketbeat·May 1, 2026
- Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 1, 2026
- Fulgent Reports First Quarter 2026 Financial ResultsYahoo Finance·May 1, 2026
- iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·Apr 30, 2026
- Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual MeetingYahoo Finance·Apr 22, 2026
- Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the FirmGlobeNewswire Inc.·Apr 17, 2026
- Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026Yahoo Finance·Apr 16, 2026
- Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDxYahoo Finance·Mar 17, 2026
- Fulgent Genetics (FLGT) Is Down 33.4% After 2025 Results And Oncology-Focused Expansion - What's ChangedYahoo Finance·Mar 2, 2026
- A Look At Fulgent Genetics (FLGT) Valuation After 2025 Results And 2026 Revenue GuidanceYahoo Finance·Mar 1, 2026
- Fulgent Genetics, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 28, 2026
- Fulgent Genetics Inc (FLGT) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst ChallengesYahoo Finance·Feb 27, 2026
- Top Midday DeclinersYahoo Finance·Feb 27, 2026
- Fulgent Genetics Q4 Earnings Call HighlightsMarketbeat·Feb 27, 2026
- Fulgent Genetics (FLGT) Earnings TranscriptMotley Fool·Feb 27, 2026
All 22 articles loaded
Price Data
Open$17.82
Previous Close$17.84
Day High$18.33
Day Low$17.81
52 Week High$31.04
52 Week Low$13.46
52-Week Range
$13.46$31.04
$18.18
Fundamentals
Market Cap$513M
P/E Ratio—
EPS$-2.40
Dividend Yield—
Dividend / Share—
ROE-6.9%
Profit Margin-23.0%
Debt / Equity—
Trading
Volume256K
Avg Volume (10D)—
Shares Outstanding28.4M
About Fulgent Genetics Inc
Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in Temple City, California.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—